<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02904941</url>
  </required_header>
  <id_info>
    <org_study_id>SA15I20099</org_study_id>
    <nct_id>NCT02904941</nct_id>
  </id_info>
  <brief_title>Human Amniotic Versus Synthetic Membrane as a Transient Skin Cover for Pediatric Burns</brief_title>
  <official_title>Human Amniotic Versus Synthetic Membrane as a Transient Skin Cover for Pediatric Burns: A Randomised Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universidad de Valparaiso</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Fondo Nacional de Investigación y Desarrollo en Salud (FONIS)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hospital Carlos Van Buren de Valparaíso, Chile</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Universidad de Valparaiso</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a randomised trial that aims to evaluate whether a transient skin cover made out of
      human amniotic membranes is effective in managing burns among pediatric patients. The primary
      outcome of this trial is the proportion of skin grafted amongst participants. Secondary
      outcomes include hospital stay and the number of surgical debridements required by included
      patients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients with burns that compromise 5% or more of total body surface area will be randomised
      to receive a membrane made out of human amnios or a synthetic cover for the acute phase of
      care. Eligible participants will be children with acute burns (&lt;24 hours) due to hot liquids
      that compromise 5% or more of total body surface area.

      Patients with burns due to fire, hot surfaces or chemical agents, those with delayed
      presentation to the emergency department (&gt;24 hours), and patients with burns that compromise
      the head or scalp (exclusively or in cases where this compromise exceeds 50% of the total
      body surface area affected by the burn). Patients whose parents do not authorise
      participation in this trial will also be excluded.

      Randomisation will be performed by a statistician unaware of the clinical management of
      included patients. The specific allocation sequence will be kept hidden from other
      investigators. Patients, outcome assessors and statisticians will also be kept unaware of
      treatment allocation. Blinding will be achieved by using image analysis software to assess
      the primary endpoint. Due to the intervention's characteristics, it will be impossible to
      perform blinding of the attending surgeon. Analyses will be performed under the intention -
      to - treat principle.

      Amniotic membrane samples will be collected by personnel that shall not provide care for
      included participants. Samples suitable for donation will come from elective caesarean
      sections. Once obtained, amniotic membranes will be stored in sterile containers and then
      sent for irradiation at a facility provided by the Comisión Chilena de Energía Nuclear
      (Chilean Nuclear Energy Comission). This sampling protocol includes exclusion of relevant
      infectious diseases as established by the Chilean Ministry of Health.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>September 2016</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Anticipated">December 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Total Grafted Skin Area</measure>
    <time_frame>Within the first 30 days after randomisation</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Length of Hospital Stay</measure>
    <time_frame>Within the first 45 days after randomisation.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Surgical Debridement</measure>
    <time_frame>Within the first 30 days after randomisation</time_frame>
    <description>Total number of surgical debridements required by participants until discharge.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Burns</condition>
  <arm_group>
    <arm_group_label>Amniotic Membrane Dressing</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Children allocated to this arm will receive skin dressings made out of human amniotic membrane. Dressings will be replaced every 72 - 96 hours.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Synthetic Dressing</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Children allocated to this arm will receive skin dressings made out of silicone as part of their wound care. Dressings will be replaced every 72 - 96 hours.</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Amniotic Membrane Dressing</intervention_name>
    <description>Amniotic membrane dressings will be made out of donated amniotic membranes from elective cesarean sections. Screening for relevant infectious diseases and irradiation will be performed from every included sample in order to minimise infectious risks. Dressings will be provided to attending surgeons during wound care at the operating theatre and removed every 72-96 hours.</description>
    <arm_group_label>Amniotic Membrane Dressing</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Synthetic Dressing</intervention_name>
    <description>Silicone dressings will used as an active comparator in this study. As with the amniotic membrane, dressings will be applied to wound care at the operating room and replaced every 72 to 96 hours.</description>
    <arm_group_label>Synthetic Dressing</arm_group_label>
    <other_name>Mepitel (R)</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Standard Wound Care</intervention_name>
    <description>Every included participant will receive standard wound care regardless of treatment allocation. Contaminants such as clothes or other materials will be removed, and all burns will be cleaned using sterile saline solutions. Clorhexidine will also be used to clean the skin. Surgical debridement under general anesthesia or procedural sedation/analgesia will be performed to every included participant, in which nonviable tissues and blisters will be removed.</description>
    <arm_group_label>Amniotic Membrane Dressing</arm_group_label>
    <arm_group_label>Synthetic Dressing</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Children with an acute burn (&lt;24 hours)

          -  Burn due to hot liquids.

          -  Total wound extension at least 5% of total body surface area.

        Exclusion Criteria:

          -  Burns due to fire, chemical burns or hot surfaces.

          -  Delayed burns (&gt;24 hours).

          -  Burns extending solely to the head or scalp.

          -  Burns whose compromise of head or scalp is 50% or more of total burn area.

          -  Refusal to participate.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>15 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>sandramontedonico@gmail.com Montedonico, M.D.</last_name>
    <role>Study Director</role>
    <affiliation>Servicio de Cirugía Pediátrica, Hospital Carlos Van Buren, Valparaíso, Chile</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Sebastián San Martín, Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Escuela de Medicina, Universidad de Valparaíso, Chile</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Felipe Martínez, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Escuela de Medicina, Universidad de Valparaíso, Chile</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Sandra Montedonico, M.D.</last_name>
    <phone>2364246</phone>
    <phone_ext>+56 32</phone_ext>
    <email>sandramontedonico@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Felipe Martinez, M.D; M.Sc.</last_name>
    <phone>99690952</phone>
    <phone_ext>+56 9</phone_ext>
    <email>felipe.martinez@uv.cl</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Hospital Carlos Van Buren</name>
      <address>
        <city>Valparaiso</city>
        <zip>2341131</zip>
        <country>Chile</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sandra Montedónico, M.D.</last_name>
      <phone>2364246</phone>
      <phone_ext>+56 32</phone_ext>
      <email>sandramontedonico@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Chile</country>
  </location_countries>
  <link>
    <url>http://www.enfermeriaaps.com/portal/guia-clinica-manejo-del-paciente-gran-quemado-minsal-chile-2016</url>
    <description>Chilean Ministry of Health Guidelines on the Management of the Burn Patient</description>
  </link>
  <reference>
    <citation>Selig HF, Lumenta DB, Giretzlehner M, Jeschke MG, Upton D, Kamolz LP. The properties of an &quot;ideal&quot; burn wound dressing--what do we need in daily clinical practice? Results of a worldwide online survey among burn care specialists. Burns. 2012 Nov;38(7):960-6. doi: 10.1016/j.burns.2012.04.007. Epub 2012 May 8.</citation>
    <PMID>22571855</PMID>
  </reference>
  <reference>
    <citation>Fairbairn NG, Randolph MA, Redmond RW. The clinical applications of human amnion in plastic surgery. J Plast Reconstr Aesthet Surg. 2014 May;67(5):662-75. doi: 10.1016/j.bjps.2014.01.031. Epub 2014 Jan 31. Review.</citation>
    <PMID>24560801</PMID>
  </reference>
  <reference>
    <citation>Fraser JF, Cuttle L, Kempf M, Phillips GE, Hayes MT, Kimble RM. A randomised controlled trial of amniotic membrane in the treatment of a standardised burn injury in the merino lamb. Burns. 2009 Nov;35(7):998-1003. doi: 10.1016/j.burns.2009.01.003. Epub 2009 May 17.</citation>
    <PMID>19447551</PMID>
  </reference>
  <reference>
    <citation>Bilic G, Zeisberger SM, Mallik AS, Zimmermann R, Zisch AH. Comparative characterization of cultured human term amnion epithelial and mesenchymal stromal cells for application in cell therapy. Cell Transplant. 2008;17(8):955-68.</citation>
    <PMID>19069637</PMID>
  </reference>
  <reference>
    <citation>Vloemans AF, Hermans MH, van der Wal MB, Liebregts J, Middelkoop E. Optimal treatment of partial thickness burns in children: a systematic review. Burns. 2014 Mar;40(2):177-90. doi: 10.1016/j.burns.2013.09.016. Epub 2013 Nov 26. Review.</citation>
    <PMID>24290852</PMID>
  </reference>
  <verification_date>December 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 4, 2016</study_first_submitted>
  <study_first_submitted_qc>September 13, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 19, 2016</study_first_posted>
  <last_update_submitted>December 14, 2017</last_update_submitted>
  <last_update_submitted_qc>December 14, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">December 15, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Children</keyword>
  <keyword>Skin Transplantation</keyword>
  <keyword>Amniotic Membrane</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Burns</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

